Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  5.00 1.95% 262.00 103,130 16:08:30
Bid Price Offer Price High Price Low Price Open Price
260.00 264.00 262.00 257.00 257.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 74.58 15.25 17.60 14.9 177
Last Trade Time Trade Type Trade Size Trade Price Currency
16:29:31 O 10,000 264.00 GBX

Eco Animal Health (EAH) Latest News

More Eco Animal Health News
Eco Animal Health Takeover Rumours

Eco Animal Health (EAH) Discussions and Chat

Eco Animal Health Forums and Chat

Date Time Title Posts
08/1/202013:52Eco Animal Health Group: Early dewormer gets OK1,117

Add a New Thread

Eco Animal Health (EAH) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-01-22 16:29:33264.0010,00026,400.00O
2020-01-22 16:28:54262.0010,00026,200.00O
2020-01-22 15:59:29259.635001,298.13O
2020-01-22 15:47:58256.493,3338,548.68O
2020-01-22 15:47:52256.493,3338,548.68O
View all Eco Animal Health trades in real-time

Eco Animal Health (EAH) Top Chat Posts

Eco Animal Health Daily Update: Eco Animal Health Group Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker EAH. The last closing price for Eco Animal Health was 257p.
Eco Animal Health Group Plc has a 4 week average price of 195p and a 12 week average price of 155p.
The 1 year high share price is 485p while the 1 year low share price is currently 155p.
There are currently 67,517,126 shares in issue and the average daily traded volume is 60,617 shares. The market capitalisation of Eco Animal Health Group Plc is £176,894,870.12.
cerrito: I can understand why you did what you did Mach100, although my reading of the latest news items is that Japan does not have ASF but does have classical swine virus. That said I am not buying more and if it does make its way to the Americas I hesitate to think what will happen to the share price. Still perplexed that ANP share price is unmoved by all of this.
cerrito: My reading is that the share price of both ANP and EAH will go nowhere till the worldwide situation of AFS is clearer and not apparent to me when that will be.
cerrito: I have gone through the annual report. Given ASF I feel I am flying blind here. I have no idea as to how much revenue and profit(however defined) comes from pigs as compared to poultry,cattle etcet. I can get nothing from the media as to what is happening in China with ASF; there are stories of it being in neighbouring countries to China and very recent outbreaks in Bulgaria and Romania and the concern it may go into Germany etcet. Luckily it does not appear to have made its way to the Americas. I hope I can make the AGM to get some clarity here. To get an idea of the importance of China remember that in 17/18 Far East(and I assume that China is the biggest contributor here) produced £14m out of the £22m adjusted ebitda. Also note per page 14 of the AR, that Chinese subsidary’s reported operating profit fell between the years from £6.4m to £5.2m. Difficult to know how this figure compares with total Group Profit from operations which went up from £14.1m to £14.7m. Page 85 tells us that of the £29.5m trade receivables at FYE, £9m were in RMB-though that high percentage would have been distorted because of extended credit terms in China. Finally page 97 shows that last year profits were more sensitive to a change in RMB FX rate than US$ rate(which makes sense given that they are both importing and exporting in US$) with a 10% change in the RMB/£ rate impacting profit by £788k. For me the upshot of these random figures is that we need to have a good handle of what is happening in China given its importance to EAH. I am going on the basis that the share price will wait to see how effective the development expenditure which will go from £3.7m in 17/18, to £5.3m in 18/19 and to £9m in 19/20 given that it will not feed through to sales till 22/23. For me good that wanting to diversify away from aivlosin. Interesting that they have £10m+of UK tax losses which no doubt will increase given r&d expenditure. Be interesting to know how they are going to deal with this situation, Also interesting to see the change in shareholder composition between June 18 and June 19. EAH has important institutional backing-institutions with 3%+ are approx. 60% of shareholding as of June 19 which added to the 10% held by the Lawrence family suggests why there is a wide trading margin. Merian/Old Mutual have gone from 8% to 4% and Schroder from 11% to 7% and we seem to have said hello to Blackrock with 4%. I find their treatment of administrative expenses frustrating-they were £7m in H1 and £12m in H1 and H2 18/19 FY and not clear why they rose between the halves; for 17/18 the July 2 2018 prelims announcement had them as £18.5m and then in the December 10 2018 Interims RNS said that 17/18m admin expenses were £13.4m which does not improve one’s mood. The truth is that I have messed up here as I have an average in price of £4.85 and difficult to see it getting back there any time soon. I hope I can make the AGM.
topvest: Share price up a tad, so results seem to be slightly better than expected. Below original market consensus of 20.3p though. Standing back from it, EAH seem to have lost a couple of years in terms of profitability growth. 20p EPS not achieved last year or the year before. Maybe 2019/20 then. That's the reason why the share price has declined, and why the main insiders sold a few years back in volume.
topvest: Share price is definitely in a bit of a downtrend, probably catching up with the poor EPS number in 2018. 2019 trade is strong and no doubt the recent weakness in sterling is now providing a headwind versus the 2018 tailwind. You would actually guess that the undershoot on 2018 will likely turn into an overshoot in 2019. I will remain patient. Think we will see well over 20p EPS this year, particularly if £ weakness continues.
topvest: Share price seems to have gone up a little at the bell though, so results seem to have gone down OK.
topvest: I suppose it explains the recent weakness in the share price though. On an actual trailing P/E of 35 maybe moving down to 27 if they now achieve 20p EPS in current financial year. A quality business, but hardly cheap. Dividend yield is 2% though which is not bad.
tanners: Panic Investor - IGR and EAH are very different businesses. EAH has as deep and wide a moat as you'll would take a competitor a long time to gain all the regulatory approvals, though I will confess I don't know whether others are attempting to develop rival products. The key is the fact that further authorisations are gained with comforting regularity; the difficult bit as I posted a few weeks back is trying to estimate what each might be worth in terms of revenue. To that end I'm compiling a spreadsheet of approvals, and attempting to link that via results to segmental revenue growth in different markets......I've gone back 5 years and whilst not entirely straightforward, I'm happy to share the results when I'm done; if anyone is interested and I think they are meaningful. In the meantime there will be periods when the share price will stagnate or even drift a bit, these movements do not concern me as long as the approvals keep coming and revenue keeps view is that we are in the infancy of a growth Company so until that story changes I'm staying invested, which hopefully will be for some years to come! PS Off topic - hadn't looked at IGR for some time but gotta say the current management are doing a fantastic real protection of product but impressive all the same, and I'm going to do some further research.
audigger: Would be strange if we didn't have interims by end of next week at latest. As for my bet, it's a little complicated but I have set a stop loss at 491 which means if the buy price hits that level my bet automatically closes. So using my £20 a point example I would lose 528-491 x 20 = 740 quid. However this amount of loss isn't guaranteed under circumstances where the share price is very volatile either due to general market volatility or major bad news for the company. If there is a dramatic fall in share price in one day, say £1,then my loss would be 100x 20 = £2000. This is why you have to stump up extra cash to secure you're bet. They call this a slippage factor and it's always higher for AIM shares that aren't particularly liquid. The same bet on BP, Lloyds or Rolls Royce would be much cheaper. In terms of profit you have a choice. You can set a level at which your bet automatically closes and you earn a known amount of profit or you can keep the bet open up to the expiry date. In this situation I would never set a level at which I close the bet with a pre-determined profit because I have absolutely no idea how much upside there could be especially if the company is taken over by a big player. If....and it's a big if, they were taken out at £10 per share whilst my bet is live then the profit would be 1000-538x20 = £9240. My realistic expectation is to make about £2000 but I am risking losing a minimum of £740 which is unlikely but possible. I'd be very surprised if there was a dramatic fall in share price and I lost £1800....but it's a possibility. I also own shares which I will keep for at least 10 years and hopefully will collect nice dividends along the way. I just don't have enough free cash right now to give me the exposure I want hence the spread bet.
audigger: Now there's a question! Basically you bet an amount on every 1 pence (referred to as a 1 point) movement in the share price. You can bet on the price increasing (going long) or decreasing (going short). At the point at which you open the bet you incur a cost which is the spread in the share price. For EAH when I took out my bet this spread was 498 (sell price)-528 (buy price). Obviously I bet on an increase in share price so I "bought" at 528. This means I immediately incur a loss as the value of my bet is set at the sell price. Say I bet £20 per point on opening my bet the cost of the spread means I'm instantly £20 x 30 (the spread) down = £600. I need the sale price to increase above 528 to be in profit. Effectively a £20 bet gives you the same exposure as owning 2000 shares. To place the bet you need to stump up a deposit/margin which for a £20 bet is about £1800. This is considerably cheaper than what it would cost to buy 2000 shares at £5 (so-called leverage). The downside however, is that you can quite easily loose all your money if the price moves against you. You can manage this risk by setting a stop-loss; a price at which the bet is closed if it moves against you. My expectation is that by June 2017 the share price should be at least £1 higher than it is today (that's no more than a judgement call!) so if that happens with the £20 bet example, the profit is £2000. You can bet any amount from 50p to thousands of pounds. The higher the bet the higher your initial outlay. Its not for the faint-hearted and I would never bet with more than I could afford to loose because it can all disappear in an instant (unlike owning the shares where there is also the opportunity to hold out for a recovery.
Eco Animal Health share price data is direct from the London Stock Exchange
Your Recent History
Eco Animal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200123 05:44:04